Medication
AG-Quetiapine Fumarate
DIN 02516969 · Angita Pharma Inc. Likely a generic
What it is
- Active ingredients
- Quetiapine — 300 mg
- Form and route
- Tablet (Immediate-Release) · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2023-02-01
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Seroquel
- PMS-Quetiapine
- Seroquel XR
- Act Quetiapine
- Riva-Quetiapine
- Pro-Quetiapine
- Quetiapine
- Quetiapine
- Ach-Quetiapine
- Jamp Quetiapine Fumarate
- Auro-Quetiapine
- Teva-Quetiapine XR
- Sandoz Quetiapine XRT
- Quetiapine XR
- Quetiapine XR
- Mint-Quetiapine
- Ach-Quetiapine Fumarate XR
- Apo-Quetiapine XR
- Nra-Quetiapine XR
- NB-Quetiapine XR
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N05AH04
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N05AH04, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.